ScarX announces approval for trial of first clinically-promising scar reduction cream
August 18, 2016 07:52 ET
|
ScarX Therapeutics
TORONTO, Aug. 18, 2016 (GLOBE NEWSWIRE) -- Toronto-based ScarX Therapeutics (ScarX) has received approval from Health Canada to begin a Phase I clinical trial of its SCX-001 nefopam cream, a...
ScarX Therapeutics closes $2 million Series A financing
February 16, 2016 09:05 ET
|
ScarX Therapeutics
TORONTO, Feb. 16, 2016 (GLOBE NEWSWIRE) -- ScarX Therapeutics, a Canadian biotechnology company commercializing innovative treatments for dermal scarring (fibrosis), has closed a $2 million Series A...